Trimeris, Inc.
Records under this name other than the patents Trimeris, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,045,552 | Pharmaceutical composition for improved administration of HIV gp41-derived peptides, and its use in therapy Term ended Term ended May 23, 2024 · From the USPTO record | Term ended | Term ended May 23, 2024 | From the USPTO record |
| US 7,514,397 | Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission Lapsed on the fee record Ended Apr 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 7, 2021 | From the USPTO record |
| US 6,623,741 | Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission Term ended Term ended Feb 29, 2020 · From the USPTO record | Term ended | Term ended Feb 29, 2020 | From the USPTO record |
| US 6,015,881 | Methods and compositions for peptide synthesis Term ended Term ended May 1, 2018 · From the USPTO record | Term ended | Term ended May 1, 2018 | From the USPTO record |
| US 6,281,331 | Methods and compositions for peptide synthesis Term ended Term ended Mar 23, 2018 · From the USPTO record | Term ended | Term ended Mar 23, 2018 | From the USPTO record |
| US 6,861,059 | Methods and compositions for treatment of HIV-1 infection using antiviral compounds in simultaneous or sequential combinations Term ended Term ended Sep 9, 2015 · From the USPTO record | Term ended | Term ended Sep 9, 2015 | From the USPTO record |
| US 6,475,491 | Treatment of HIV and other viral infections using combinatorial therapy Term ended Term ended Jun 7, 2015 · From the USPTO record | Term ended | Term ended Jun 7, 2015 | From the USPTO record |
| US 6,562,787 | Hybrid polypeptides with enhanced pharmacokinetic properties Lapsed on the fee record Ended May 13, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 13, 2015 | From the USPTO record |
| US 6,541,020 | Methods and compositions for administration of therapeutic reagents Lapsed on the fee record Ended Apr 1, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2015 | From the USPTO record |
| US 6,479,055 | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission Lapsed on the fee record Ended Nov 12, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 12, 2014 | From the USPTO record |